Condition: PASC Post Acute Sequelae of COVID 19 · Fatigue · Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.
This description comes directly from the study's public registry record.
Anthony Gonzalez · 443-923-2716 · gonzalezan@kennedykrieger.org
Vikram Chib, PhD
Always discuss trial participation with your own doctor first.
| Kennedy Krieger Institute | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07278388